Terms: = Germ cell tumor AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Diagnosis
8 results:
1. sil-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
Barak V; Kalickman I; Pe'er J
Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
[TBL] [Abstract] [Full Text] [Related]
2. Pre-diagnostic levels of sVEGFR2, sTNFR2, sil-2Rα and sil-6R are associated with glioma risk: A nested case-control study of repeated samples.
Wu WY; Späth F; Wibom C; Björkblom B; Dahlin AM; Melin B
Cancer Med; 2022 Feb; 11(4):1016-1025. PubMed ID: 35029050
[TBL] [Abstract] [Full Text] [Related]
3. [Metachronous Development of Mantle cell Lymphoma during Active Surveillance in a Patient with Stage I Testicular Cancer].
Sano K; Kimura T; Kawai K; Ikeda A; Ishitsuka R; Kandori S; Waku N; Hoshi A; Kojima T; Joraku A; Hashimoto R; Nishiyama H
Hinyokika Kiyo; 2018 Dec; 64(12):509-513. PubMed ID: 30831668
[TBL] [Abstract] [Full Text] [Related]
4. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
[TBL] [Abstract] [Full Text] [Related]
5. Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.
Wong ET; Timmons J; Callahan A; O'Loughlin L; Giarusso B; Alsop DC
BMC Cancer; 2016 Nov; 16(1):914. PubMed ID: 27876012
[TBL] [Abstract] [Full Text] [Related]
6. Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma.
Egler RA; Burlingame SM; Nuchtern JG; Russell HV
Clin Cancer Res; 2008 Nov; 14(21):7028-34. PubMed ID: 18980999
[TBL] [Abstract] [Full Text] [Related]
7. Adenoid basal carcinoma of the cervix: a potential pitfall in cervicovaginal cytology.
Powers CN; Stastny JF; Frable WJ
Diagn Cytopathol; 1996 Mar; 14(2):172-7. PubMed ID: 8964176
[TBL] [Abstract] [Full Text] [Related]
8. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract] [Full Text] [Related]
